BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16150246)

  • 21. Successful thyroid tissue ablation as defined by a negative whole-body scan or an undetectable thyroglobulin: a comparative study.
    Karam M; Feustel PJ; Postal ES; Cheema A; Goldfarb CR
    Nucl Med Commun; 2005 Apr; 26(4):331-6. PubMed ID: 15753792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Guidelines for the management of differentiated thyroid cancers].
    Ann Endocrinol (Paris); 2007 Dec; 68 Suppl 2():S57-72. PubMed ID: 18342281
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The British Thyroid Association guidelines for the management of thyroid cancer in adults.
    Watkinson JC;
    Nucl Med Commun; 2004 Sep; 25(9):897-900. PubMed ID: 15319594
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution.
    Wong R; Topliss DJ; Bach LA; Hamblin PS; Kalff V; Long F; Stockigt JR
    Intern Med J; 2009 Mar; 39(3):156-63. PubMed ID: 19383064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current approaches to the treatment of well-differentiated thyroid cancer.
    Angelos P
    Oncology (Williston Park); 2002 Mar; 16(3):309-15; discussion 315, 318, 323-4. PubMed ID: 15046390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment of differentiated thyroid carcinoma.
    Cox AE; LeBeau SO
    Radiol Clin North Am; 2011 May; 49(3):453-62, vi. PubMed ID: 21569904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
    Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Differentiated thyroid cancer -- 2009].
    Konrády A
    Orv Hetil; 2011 Jan; 152(5):163-70. PubMed ID: 21247857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
    Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
    Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
    Pelizzo MR; Boschin IM; Toniato A; Piotto A; Bernante P; Pagetta C; Rampin L; Rubello D
    Eur J Surg Oncol; 2006 Dec; 32(10):1144-8. PubMed ID: 16872798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total thyroidectomy for differentiated thyroid cancer.
    Sosa JA; Udelsman R
    J Surg Oncol; 2006 Dec; 94(8):701-7. PubMed ID: 17131393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
    Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level.
    Elisei R; Agate L; Viola D; Matrone A; Biagini A; Molinaro E
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):331-44. PubMed ID: 24891165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
    Kim SJ; Lee TH; Kim IJ; Kim YK
    Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
    Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
    Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid cancer in children.
    Dinauer C; Francis GL
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):779-806, vii. PubMed ID: 17673128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiated thyroid cancer in children: diagnosis and management.
    Dinauer CA; Breuer C; Rivkees SA
    Curr Opin Oncol; 2008 Jan; 20(1):59-65. PubMed ID: 18043257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.